Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 375

1.

Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget's disease of the vulva: a pilot study.

Raspagliesi F, Fontanelli R, Rossi G, Ditto A, Solima E, Hanozet F, Kusamura S.

Gynecol Oncol. 2006 Nov;103(2):581-6. Epub 2006 Jun 21.

PMID:
16793128
2.

5-Aminolevulinic acid-based photodynamic therapy for the treatment of two patients with extramammary Paget's disease.

Mikasa K, Watanabe D, Kondo C, Kobayashi M, Nakaseko H, Yokoo K, Tamada Y, Matsumoto Y.

J Dermatol. 2005 Feb;32(2):97-101.

PMID:
15906538
3.

Photodynamic therapy following carbon dioxide laser enhances efficacy in the treatment of extramammary Paget's disease.

Fukui T, Watanabe D, Tamada Y, Matsumoto Y.

Acta Derm Venereol. 2009;89(2):150-4. doi: 10.2340/00015555-0623.

4.

Photodynamic therapy for the treatment of extramammary Paget's disease.

Shieh S, Dee AS, Cheney RT, Frawley NP, Zeitouni NC, Oseroff AR.

Br J Dermatol. 2002 Jun;146(6):1000-5.

PMID:
12072068
5.

Incomplete efficacy of 5-aminolevulinic acid (5 ALA) photodynamic therapy in the treatment of widespread extramammary Paget's disease.

Al Yousef A, Boccara O, Moyal-Barracco M, Zimmermann U, Saiag P.

Photodermatol Photoimmunol Photomed. 2012 Feb;28(1):53-5. doi: 10.1111/j.1600-0781.2011.00635.x.

PMID:
22212005
6.

Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity.

Akita Y, Kozaki K, Nakagawa A, Saito T, Ito S, Tamada Y, Fujiwara S, Nishikawa N, Uchida K, Yoshikawa K, Noguchi T, Miyaishi O, Shimozato K, Saga S, Matsumoto Y.

Br J Dermatol. 2004 Aug;151(2):472-80.

PMID:
15327557
7.

Photodynamic therapy with M-ALA as non surgical treatment option in patients with primary extramammary Paget's disease.

Fontanelli R, Papadia A, Martinelli F, Lorusso D, Grijuela B, Merola M, Solima E, Ditto A, Raspagliesi F.

Gynecol Oncol. 2013 Jul;130(1):90-4. doi: 10.1016/j.ygyno.2013.04.008. Epub 2013 Apr 13.

PMID:
23591398
8.

Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.

Britton JE, Goulden V, Stables G, Stringer M, Sheehan-Dare R.

Br J Dermatol. 2005 Oct;153(4):780-4.

PMID:
16181460
9.

Photodynamic therapy for inoperable vulval Paget's disease using delta-aminolaevulinic acid: successful management of a large skin lesion.

Henta T, Itoh Y, Kobayashi M, Ninomiya Y, Ishibashi A.

Br J Dermatol. 1999 Aug;141(2):347-9.

PMID:
10468815
10.

Successful photodynamic therapy of vulval Paget's disease using a novel patch-based delivery system containing 5-aminolevulinic acid.

Zawislak AA, McCarron PA, McCluggage WG, Price JH, Donnelly RF, McClelland HR, Dobbs SP, Woolfson AD.

BJOG. 2004 Oct;111(10):1143-5. No abstract available.

11.

Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.

Kuijpers DI, Thissen MR, Thissen CA, Neumann MH.

J Drugs Dermatol. 2006 Jul-Aug;5(7):642-5.

PMID:
16865869
12.

Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.

Calzavara-Pinton PG, Venturini M, Sala R, Capezzera R, Parrinello G, Specchia C, Zane C.

Br J Dermatol. 2008 Jul;159(1):137-44. doi: 10.1111/j.1365-2133.2008.08593.x. Epub 2008 Jul 1.

PMID:
18489606
13.

Noninvasive extramammary Paget's disease treated with photodynamic therapy: case series from the Roswell Park Cancer Institute.

Housel JP, Izikson L, Zeitouni NC.

Dermatol Surg. 2010 Nov;36(11):1718-24. doi: 10.1111/j.1524-4725.2010.01734.x. Epub 2010 Sep 17.

PMID:
20849546
14.

Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.

Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB; Phase IV ALA-PDT Actinic Keratosis Study Group..

Br J Dermatol. 2006 Dec;155(6):1262-9.

PMID:
17107399
15.

Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.

Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes LE, Kaufmann R, De Rie M, Legat FJ, Stender IM, Solér AM, Wennberg AM, Wong GA, Larkö O.

Br J Dermatol. 2003 Dec;149(6):1242-9.

PMID:
14674903
16.

Photodynamic therapy for superficial bladder cancer under local anaesthetic.

Shackley DC, Briggs C, Gilhooley A, Whitehurst C, O'Flynn KJ, Betts CD, Moore JV, Clarke NW.

BJU Int. 2002 May;89(7):665-70.

18.

An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer.

Attili SK, Lesar A, McNeill A, Camacho-Lopez M, Moseley H, Ibbotson S, Samuel ID, Ferguson J.

Br J Dermatol. 2009 Jul;161(1):170-3. doi: 10.1111/j.1365-2133.2009.09096.x. Epub 2009 Mar 19.

PMID:
19302071
19.

Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy.

Morton CA, Whitehurst C, Moore JV, MacKie RM.

Br J Dermatol. 2000 Oct;143(4):767-72.

PMID:
11069454
20.

Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.

Hasegawa T, Suga Y, Mizuno Y, Haruna K, Ogawa H, Ikeda S.

J Dermatol. 2010 Jul;37(7):623-8. doi: 10.1111/j.1346-8138.2010.00850.x.

PMID:
20629828

Supplemental Content

Support Center